Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC254
Biochips have a wide range of diversified applications ranging from accelerated drug development to disease marker identification and include a large number of applications related to research especially in the fields of genotyping, genomics and proteomics. Moreover, rapid increase in spending, especially on clinical research and allocation of substantial resources for proteomic and genomic research are some of the key factors anticipated to fuel the global biochips market over the forecast period. In addition, bio microsystem is considered as a group of integrated and miniaturized devices generally used for biochemical and biological reactions in monitoring, diagnostics, research and development and therapy. In addition, some of the key advantages of bio microsystems include integrated intelligence, parallelism, speed, low cost, redundancy and complexity. Moreover, biochip is considered to be one of most proficient examples of development in technologies of bio microsystems. Also, a biochip is a vast collection of rearranged microarrays, especially on a solid substrate, that allows thousands of difficult and complex biochemical reactions. In addition, biochips are widely used in a variety of major applications such as research in biotechnology as well as proteomics and genomics, and development and drug screening of molecular diagnostics.
An increasing need for the reduction of overall turnaround time as well as miniaturization of clinical and biological tests deployed for diagnosis and research have bolstered the overall demand for biochips and bio-array procedures, thus driving the global biochips market. In addition, rapid technical developments associated with aforementioned techniques as well as a wide portfolio of product on their offerings owing to new product innovations are some of the key factors anticipated to furnish the researchers with a wide range of choices to primarily suit with their specific requirements. However, since biochip systems consist of formatted probes in micro scales, especially on glass surfaces, they further require some automatic robotic tools for scanning and handling the micro scale samples. Furthermore, bioinformatics tools are in turn needed for analysis of the data. Demand for such specific techniques and tools for implementation of biochips technology is anticipated to consider biochips as a sophisticated and relatively more expensive technology.
The global biochips market can be segmented on the basis of type, end-user, fabrication technology and region. On the basis of type, the global biochips market can be segmented into DNA chips, lab on a chip, protein chips and other arrays. On the basis of end user, the global biochips market can be segmented into biotechnology, pharmaceutical, hospitals, diagnostic centers, research institutes, academics and others. On the basis of fabrication technology, the global biochips market can be segmented into micro arrays and micro fluidics. On the basis of region, the global biochips market can be segmented into North America, Latin America, Europe, Middle East & Africa and Asia-Pacific. The significant demand of biochips in healthcare applications in Asia-Pacific is projected to be the major driving factor for the growth of global biochips market. The U.S. is anticipated to account for the largest share and lead the overall demand for biochips owing to the increasing industrial production over the last few years. The markets in other developing countries such as Brazil, Russia, Poland, Indonesia, New Zealand, Argentina and India among others are also anticipated to grow rapidly throughout the forecast period.
Major players operating in the global biochips market are focusing on some key market strategies such as mergers and acquisitions to keep hold in the ever competitive market. Moreover, they are concentrating on collaborating with local players to increase their market reach as well as strengthen their goodwill in the global market. Some of the major players in the global biochips market include Sigma Aldrich Corp., EMD Millipore, Caliper Life Sciences Inc., Agilent Technologies, and Abbott Laboratories among others.
Related Reports
Blood Clot Retrieval Devices Market Size (By Stroke Type - Ischemic Stroke, Hemorrhagic Stroke (Rupturing Of Arteries), Transient Ischemic Attack; By Device Type - Mechanical Embolus Removal Devices, Penumbra Blood Clot Retrieval Devices, Stent Retrievers, Ultrasound Assisted Devices; By End Users - Hospitals, Diagnostic Centers, Clinics, Ambulatory Surgical Centers) - Global Industry Size, Share, Trends, And Forecast, 2018-2026
Introduction Blood clot retrieval is a surgical technique that involves mechanical removal of blood clot from the patient’s brain. This technique is mainly used for the treatment of ischemic strokes caused due to the blood clots, which reduces the risk of...
Insulin Management System Market Size (By Product Type - Insulin Pen Injectors, Needle And Syringe, Insulin Jet Injectors, Implantable Pumps, External Insulin Pumps, Insulin Patches; By Mode Of Action - Short Acting Insulin, Intermediate Acting Insulin, Rapid Acting Insulin, Pre-Mixed Insulin; By Diabetes Type - Diabetes I, Diabetes II; By End User - Hospital & Clinics, Ambulatory Centers) - Global Industry Size, Share, Trends, And Forecast, 2018 - 2026
Introduction Diabetes is a metabolic disease in which consist of elevated blood glucose levels over a prolonged period. It is caused due to either pancreas not able to produce enough insulin or cells of the body not responding to the insulin produced. Insulin m...
Infant Formula Ingredients Market ( By Types - Carbohydrates, Oils & Fats, Proteins, Vitamins & Minerals, Prebiotics; By Form - Powder, Liquid & Semi-Liquid; By Application - Growing-Up Milk (Infants Over 12 Months), Standard Infant Formula (0–6-Month-Old Infant), Follow-On Formula (6–12 Month-Old Infant), Specialty Formula) - Global Industry Size, Share, Trends and Forecast, 2018 - 2026
Introduction A number of different types of nutrition are for infants are available in the market. The infant formulas comprise of purified cow’s milk as a source of protein, blend of fat source form vegetable oils, vitamin-mineral mix, lactose as a carbo...
Safety Prefilled Syringe Market (By Type- Specialty prefilled syringes, Conventional prefilled syringes, Safety prefilled syringes; By Barrel Type - Dual chambered, Customized prefilled syringes, Single chambered; Product Type- Plastic-based Prefilled Syringes, Glass-based Prefilled Syringe; By Application- Hormonal disorders, Oncology, Auto-immune diseases, Diabetes, Anemia)- Global Industry Size, Share, Trends, and Forecast, 2018-2026
Introduction Prefilled syringes are ready-to-use pharmaceutical products used to deliver the medication to the patients. They are disposable syringes which contain substance or liquid use to administered to a patient. These syringes deliver the accurate dose of...
Digital Pill Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026
Introduction Digital pill is a pharmaceutical dosage form and it is consists of ingestible sensor inside of a pill. A small, swallowable sensor named AbilifyMyCite that tracks path when the patient swallows their medicines. The tablet is precisely targeted for ...
Fish Collagen Hydrolysate Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026
Introduction Fish Collagen Hydrolyzed is mass-produced from collagen and it is the primary protein originates from bones and skin. Animal collagen is naturally extracted from porcine orbovine skin whereas fish collagen is made from the skin of ocean ordeep wate...
